Therefore, understanding the precise molecular mechanisms underlying regulation of negative regulators of PI3K/Akt signaling could provide new insights into the pathogenesis of cancers and lead to more effective anticancer therapy strategies. This evidence concerns the gene AKT1 and cancer.